<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-antibiotics-10-00092">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Liu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Qiu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Morisseau</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Hwang</surname>
    <given-names>S.H.</given-names>
   </name>
   <name>
    <surname>Tsai</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Ulu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chiamvimonvat</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Hammock</surname>
    <given-names>B.D.</given-names>
   </name>
  </person-group>
  <article-title>Inhibition of soluble epoxide hydrolase contributes to the anti-inflammatory effect of antimicrobial triclocarban in a murine model</article-title>
  <source>Toxicol. Appl. Pharmacol.</source>
  <year>2011</year>
  <volume>255</volume>
  <fpage>200</fpage>
  <lpage>206</lpage>
  <pub-id pub-id-type="doi">10.1016/j.taap.2011.06.017</pub-id>
  <pub-id pub-id-type="pmid">21741984</pub-id>
 </element-citation>
</ref>
